-
公开(公告)号:US20230365640A1
公开(公告)日:2023-11-16
申请号:US18028747
申请日:2021-09-29
Applicant: Academia Sinica
Inventor: Shie-Liang HSIEH , Pei-Shan SUNG
CPC classification number: C07K14/4726 , A61P31/14 , A61P31/16 , A61K38/00
Abstract: Disclosed herein is a CLEC2 fusion protein comprising a first polypeptide and a second polypeptide coupled to the upstream of the first polypeptide. According to embodiments of the present disclosure, the first and the second polypeptides respectively comprise the amino acid sequences of SEQ ID NOs: 1 and 2. Also disclosed therein are uses of the CLEC2 fusion protein in treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and treating influenza virus infection.
-
公开(公告)号:US20230346872A1
公开(公告)日:2023-11-02
申请号:US17922977
申请日:2021-05-06
Applicant: Academia Sinica
Inventor: Che MA , Jia-Tsrong JAN
IPC: A61K36/896 , A61K45/06 , A61P31/14
CPC classification number: A61K36/896 , A61K45/06 , A61P31/14
Abstract: Disclosed herein is a method for treating or preventing a coronavirus infection, which comprises administering to a subject in need thereof an effective amount of a composition comprising Flt3 receptor interacting lectin (FRIL) from Lablab purpureus. Also disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable excipient, a Lablab purpureus FRIL, and an additional therapeutic agent.
-
公开(公告)号:US11739122B2
公开(公告)日:2023-08-29
申请号:US16731084
申请日:2019-12-31
Applicant: Academia Sinica
Inventor: Tsung-Lin Li , Chun-Man Huang , Kuan-Hung Lin
Abstract: A teicoplanin derivative useful for treating an infectious disease, having the structure of formula (I):
or the pharmaceutically acceptable salt, solvate, stereoisomer, derivative or prodrug thereof. In an exemplary compound of formula (I), R1 is
R2 is H, R3 is —N(CH3)2, and R4 is H.-
公开(公告)号:US11737466B2
公开(公告)日:2023-08-29
申请号:US16708653
申请日:2019-12-10
Applicant: National Taiwan University , ACADEMIA SINICA
Inventor: Chi-Te Liu , Wen-Chin Yang , Yen-Yu Liu , Chu-Ning Huang , Chan-Pin Lin
Abstract: The present invention provides a method of improving the ability of plants to resistance diseases, comprising using a strain of Bacillus amyloliquefaciens and a Bidens plant extract; and the Bidens plant extract enhances the ability of the Bacillus amyloliquefaciens to inhibit the growth of the Acidovorax avenae subsp. citrulli, increases the metabolic activity of the Bacillus amyloliquefaciens, increases the amount of the biofilm formation of the Bacillus amyloliquefaciens, and maintains the alive number of the Bacillus amyloliquefaciens.
-
公开(公告)号:US11717801B2
公开(公告)日:2023-08-08
申请号:US17625349
申请日:2020-08-05
Applicant: Academia Sinica
Inventor: Michael Hsiao , Ming-Che Hsieh , Zhen Bao , Ming-Hsien Chan , Ru-Shi Liu , An-Bang Wang , Chia-Chih Chu
IPC: B01J19/00
CPC classification number: B01J19/0093 , B01J2219/00873 , B01J2219/00957 , B01J2219/00961 , B01J2219/00963 , B01J2219/00972
Abstract: Disclosed herein is a micro-reactor for synthesizing a molecule, for example, compound, a nanoparticle, or a quantum dot. According to embodiments of the present disclosure, the apparatus comprises a processor, a storage unit, a reaction unit, a detector, and a collector, in which the storage unit and the reaction unit are independently controlled by the process. Optionally, the present micro-reactor further comprises a diagnostic device for performing a diagnostic test on a biological sample by use of the molecule. Also disclosed wherein are methods of diagnosing and treating a disease in a subject with the aid of the present micro-reactor.
-
公开(公告)号:US20230233549A1
公开(公告)日:2023-07-27
申请号:US18184364
申请日:2023-03-15
Applicant: Academia Sinica
Inventor: Rong-Jie CHEIN , Pan-Chyr YANG , Chi-Huey WONG , Ming-Shiu LIN , Ting-Jen CHENG , Ting-Hung Rachel CHOU
IPC: A61K31/47 , A61P35/00 , A61K45/06 , C07D215/233
CPC classification number: A61K31/47 , A61P35/00 , A61K45/06 , C07D215/233
Abstract: Provided herein are compounds of Formula (I). The disclosure provides new compounds, compositions, and methods for treating, delaying, and/or preventing the adverse effects of proliferative diseases, such as cancers including, for example, lung cancer, breast cancer, ovarian cancer, prostate cancer, head cancer, neck cancer, head and neck cancer, or leukemia (e.g., cancer resistant to treatment by one or more microtubule-targeting agents (e.g., cancer resistant to multiple drugs associated with P-glycoprotein (P-gp) overexpression)). Provided are methods of inhibiting polymerization of a cancer cell microtubule in a subject in need thereof or a cell, tissue, or biological sample, binding β-tubulin, inhibiting microtubule assembly and, inducing apoptosis in a cancer cell resistant to multiple drugs in a tissue, biological sample, or subject. Also provided in the present disclosure are pharmaceutical compositions, kits, and methods of using the compounds for treating any of the target diseases described herein.
-
公开(公告)号:US20230204508A1
公开(公告)日:2023-06-29
申请号:US18084997
申请日:2022-12-20
Applicant: ACADEMIA SINICA
Inventor: Pei-Kuen WEI , Sheng-Hann WANG , Ting-Wei CHANG
IPC: G01N21/552
CPC classification number: G01N21/554 , G01N2021/177
Abstract: A detection method and a detection system for detecting objects of interest attached to a surface of a plurality of reporters, wherein the plurality of reporters are flowing in a microfluidic chip and illuminated by a light source. The detection method has following steps: obtaining a plurality of local surface plasmon resonance (LSPR) spectral images of each the plurality of the reporters individually, wherein each of the LSPR spectral images has a brightness of a long wavelength band (BA) and a brightness of a short wavelength band (BB); calculating a spectral image brightness contrast γ for each of the LSPR spectral images, wherein
γ
=
B
A
-
B
B
B
A
+
B
B
;
and, defining a positive threshold for |γ|≥0.1.-
公开(公告)号:US20230203521A1
公开(公告)日:2023-06-29
申请号:US17923455
申请日:2021-04-29
Applicant: Academia Sinica
Inventor: Su-Ying Yeh , Hsin-Hung Lin , Maurice S. B. Ku , Wen-Hsiung Li
IPC: C12N15/82
CPC classification number: C12N15/8269 , C12N15/8265
Abstract: A transgenic rice plant containing in its genome a recombinant DNA construct that includes a first nucleic acid having a sequence of a first Golden 2-like transcription factor (GLK) gene operably linked to its natural promoter and 5′ untranslated region (5′UTR), and a second nucleic acid having a sequence of a second GLK gene operably linked to its natural promoter and 5′UTR, the second GLK gene being distinct from the first GLK gene. The first GLK gene and the second GLK gene are both from a C4 plant and the transgenic rice plant exhibits a 65-106% increase in shoot biomass and a 50-95% increase in grain yield, as compared to an untransformed wild-type rice plant. Also provided is a method for producing the transgenic rice plant and a recombinant DNA construct that can be used in the method.
-
公开(公告)号:US11674958B2
公开(公告)日:2023-06-13
申请号:US16832396
申请日:2020-03-27
Applicant: Academia Sinica
Inventor: Ying-Chih Chang , Han-Chung Wu , Po-Yuan Tseng , Jen-Chia Wu
IPC: G01N33/543 , G01N33/574 , G01N1/40 , C07K17/14 , C07K16/30
CPC classification number: G01N33/54386 , C07K16/30 , C07K17/14 , G01N1/405 , G01N33/54393 , G01N33/57492
Abstract: This invention relates to a surface coating for capture circulating rare cells, comprising a nonfouling composition to prevent the binding of non-specific cells and adsorption of serum components; a bioactive composition for binding the biological substance, such as circulating tumor cells; with or without a linker composition that binds the nonfouling and bioactive compositions. The invention also provide a surface coating for capture and purification of a biological substance, comprising a releasable composition to release the non-specific cells and other serum components; a bioactive composition for binding the biological substance, such as circulating tumor cells; with or without a linker composition that binds the releasable and bioactive compositions. The present invention also discloses a novel microfluidic chip, with specific patterned microstructures to create a flow disturbance and increase the capture rate of the biological substance.
-
公开(公告)号:US20230151372A1
公开(公告)日:2023-05-18
申请号:US17961595
申请日:2022-10-07
Applicant: Academia Sinica
Inventor: Patrick Ching-Ho Hsieh , Yuan-Yuan Cheng
CPC classification number: C12N15/52 , C12N15/86 , A61P9/10 , C12N2750/14143
Abstract: The present invention provides a gene delivery vehicle comprising a heterologous genome capable of upregulating the expression of HMGCS2 in human heart and, in particular, in the cardiomyocyte (CM). Upregulating the expression of HMBCS2 causes a metabolic switch that facilitates CM dedifferentiation and regeneration under myocardial infarction or hypoxic conditions. The present invention also provides a method of therapy for protection and/or regeneration of the human heart and, in particular, in the CM by administration of the composition of the present invention to the patient.
-
-
-
-
-
-
-
-
-